We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UKs Makes Approval of Innovative Medicines a Top Priority
UKs Makes Approval of Innovative Medicines a Top Priority
August 15, 2007
It is in the public interest to bring innovative medicines and medical devices to the market as soon as their safety and efficacy can be properly assessed, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) says in its corporate plan 2007-08 to 2011-12.